Biologics: Targets and Therapy
Volume 15, 2021 - Issue
Open access
205
Views
3
CrossRef citations to date
0
Altmetric
Original Research
An Australian Real-World Study of Treatment Persistence of Ustekinumab in Crohn’s Disease
Tzu Hsiang Chien1 Janssen-Cilag Pty Ltd, Sydney, NSW, AustraliaCorrespondence[email protected]
View further author information
, View further author information
Andrea Puig1 Janssen-Cilag Pty Ltd, Sydney, NSW, Australia
https://orcid.org/0000-0002-7730-6310View further author information
Thang Khuong2 Prospection Pty Ltd, Sydney, NSW, AustraliaView further author information
, Mahsa H Kouhkamari2 Prospection Pty Ltd, Sydney, NSW, AustraliaView further author information
, Samuel Che2 Prospection Pty Ltd, Sydney, NSW, AustraliaView further author information
& Tom Hsun-Wei Huang1 Janssen-Cilag Pty Ltd, Sydney, NSW, Australia
https://orcid.org/0000-0001-7221-6423View further author information
Pages 237-245
|
Published online: 16 Jun 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.